Summary This article explores the potential of intermittent fasting (IF) for achieving type 2 diabetes remission, particularly in real-world settings. It examines recent research and case studies highlighting the effectiveness of IF in improving glycemic […]
Summary Researchers have developed a groundbreaking vascularized model of stem cell-derived islet cells, offering new hope for diabetes treatment. This model mimics the natural environment of the pancreas more effectively than previous models, paving the […]
Summary Scientists have identified the PPP1R3B gene as a key regulator of how the liver stores energy, impacting metabolic disease risk. This discovery paves the way for personalized treatments for type 2 diabetes and fatty […]
Summary Researchers have identified a potential new treatment strategy for Type 1 diabetes by targeting the TYK2 protein, which plays a crucial role in inflammation. Blocking TYK2 not only protects insulin-producing beta cells in the […]
Summary This article explores the intricate relationship between obesity, beta-cell function, and colonic inflammation in the context of diabetes. It examines how obesity can lead to both increased and decreased beta-cell function, with colonic inflammation […]
Summary New research suggests a link between enteroviral infections and the development of type 1 diabetes (T1D). Studies reveal that persistent, low-level enteroviral infections in the pancreas may trigger an autoimmune attack on insulin-producing cells. […]
Summary The mylife CamAPS FX app, a hybrid closed-loop system for Type 1 diabetes management, is now available on iOS devices in the UK. This expansion offers greater choice and flexibility for individuals managing T1D. […]
Summary Teplizumab, the first drug to delay type 1 diabetes, offers new hope. It delays progression to stage 3 by approximately two years, giving patients valuable time before insulin dependence. This breakthrough paves the way […]
Summary Adults diagnosed with type 1 diabetes face significantly increased risks of cardiovascular disease and mortality. Modifiable risk factors such as smoking, obesity, and poor glucose control contribute significantly to these adverse outcomes. Early intervention […]
Summary GLP-1 receptor agonists are transforming diabetes and obesity treatment. These medications mimic natural hormones, promoting insulin release, reducing appetite, and leading to significant weight loss. They offer new hope for patients struggling with these […]
© 2025 Newsguru LTD. All rights reserved.